TrialBlood advances2025

Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study.

Rubina Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.